BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dominari A, Hathaway III D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Maher M, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: A comprehensive review of the literature. World J Virol 2020; 9(5): 67-78 [PMID: 33362999 DOI: 10.5501/wjv.v9.i5.67]
URL: https://www.wjgnet.com/2220-3249/full/v9/i5/67.htm
Number Citing Articles
1
Muhammad Shahbaz Aslam, Syed Zohaib Javaid Zaidi, Rabail Hassan Toor, Iram Gull, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed, Muhammad Amin Athar, Christian Harito, Sammer-ul Hassan. Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral EffectMaterials 2021; 14(12): 3318 doi: 10.3390/ma14123318
2
Tao Liu, Shengdong Liu, Tao Li, Jingjing Zhang. Thymosin a1 use is not associated with reduced COVID-19 mortalityThe American Journal of Emergency Medicine 2021;  doi: 10.1016/j.ajem.2021.04.043
3
ChenLu Huang, Ling Fei, Wei Xu, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen. Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score MatchingFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.664776